Freedom from reoperation, aortic insufficiency and New York Heart Association classification at follow-up
| . | Total (n = 71) . | Trileaflet aortic valve (n = 53) . | Bicuspid aortic valve (n = 18) . |
|---|---|---|---|
| Follow-up duration (years), mean (SD) | 3.9 (1.1) | 3.9 (1.2) | 3.9 (1.1) |
| Follow-up duration (years), median (IQR) | 4.1 (1.5) | 4.2 (1.5) | 3.9 (1.8) |
| Completeness of follow-up (%), n (%) | 67 (94) | 50 (94) | 17 (94) |
| Reoperation for aortic valve dysfunction, n (%) | 4 (6) | 3 (6) | 1 (6) |
| NYHA class on most recent follow-up, n (%) | |||
| I | 60 (85) | 45 (85) | 15 (83) |
| II | 10 (14) | 7 (13) | 3 (17) |
| III and IV | 1 (1.4) | 1 (2) | 0 (0) |
| AI grade at most recent follow-up, n (%)a | |||
| Zero trace | 17 (25) | 7 (14) | 10 (56) |
| 1+ | 37 (54) | 30 (60) | 7 (39) |
| 2+ | 10 (15) | 10 (20) | 0 (0) |
| 3+ | 0 (0) | 0 (0) | 0 (0) |
| 4+ | 4 (6)b | 3 (6) | 1 (6) |
| Follow-up mean AV gradient (mmHg), median (IQR) | 10 (8–16) | 10 (8–16) | 12 (9–16) |
| Composite outcome: AV reoperation or ≥2+ AI (%), n (%) | 14 (20) | 13 (25) | 1 (6) |
| . | Total (n = 71) . | Trileaflet aortic valve (n = 53) . | Bicuspid aortic valve (n = 18) . |
|---|---|---|---|
| Follow-up duration (years), mean (SD) | 3.9 (1.1) | 3.9 (1.2) | 3.9 (1.1) |
| Follow-up duration (years), median (IQR) | 4.1 (1.5) | 4.2 (1.5) | 3.9 (1.8) |
| Completeness of follow-up (%), n (%) | 67 (94) | 50 (94) | 17 (94) |
| Reoperation for aortic valve dysfunction, n (%) | 4 (6) | 3 (6) | 1 (6) |
| NYHA class on most recent follow-up, n (%) | |||
| I | 60 (85) | 45 (85) | 15 (83) |
| II | 10 (14) | 7 (13) | 3 (17) |
| III and IV | 1 (1.4) | 1 (2) | 0 (0) |
| AI grade at most recent follow-up, n (%)a | |||
| Zero trace | 17 (25) | 7 (14) | 10 (56) |
| 1+ | 37 (54) | 30 (60) | 7 (39) |
| 2+ | 10 (15) | 10 (20) | 0 (0) |
| 3+ | 0 (0) | 0 (0) | 0 (0) |
| 4+ | 4 (6)b | 3 (6) | 1 (6) |
| Follow-up mean AV gradient (mmHg), median (IQR) | 10 (8–16) | 10 (8–16) | 12 (9–16) |
| Composite outcome: AV reoperation or ≥2+ AI (%), n (%) | 14 (20) | 13 (25) | 1 (6) |
Three trileaflet patients do not have follow-up AI grades: 2 were lost to follow-up and 1 died prior to follow-up from a cause unrelated to his surgery.
This includes the patients who subsequently underwent reoperation.
AI: aortic insufficiency; AV: aortic valve; IQR: interquartile range; NYHA: New York Heart Association; SD: standard deviation.
Freedom from reoperation, aortic insufficiency and New York Heart Association classification at follow-up
| . | Total (n = 71) . | Trileaflet aortic valve (n = 53) . | Bicuspid aortic valve (n = 18) . |
|---|---|---|---|
| Follow-up duration (years), mean (SD) | 3.9 (1.1) | 3.9 (1.2) | 3.9 (1.1) |
| Follow-up duration (years), median (IQR) | 4.1 (1.5) | 4.2 (1.5) | 3.9 (1.8) |
| Completeness of follow-up (%), n (%) | 67 (94) | 50 (94) | 17 (94) |
| Reoperation for aortic valve dysfunction, n (%) | 4 (6) | 3 (6) | 1 (6) |
| NYHA class on most recent follow-up, n (%) | |||
| I | 60 (85) | 45 (85) | 15 (83) |
| II | 10 (14) | 7 (13) | 3 (17) |
| III and IV | 1 (1.4) | 1 (2) | 0 (0) |
| AI grade at most recent follow-up, n (%)a | |||
| Zero trace | 17 (25) | 7 (14) | 10 (56) |
| 1+ | 37 (54) | 30 (60) | 7 (39) |
| 2+ | 10 (15) | 10 (20) | 0 (0) |
| 3+ | 0 (0) | 0 (0) | 0 (0) |
| 4+ | 4 (6)b | 3 (6) | 1 (6) |
| Follow-up mean AV gradient (mmHg), median (IQR) | 10 (8–16) | 10 (8–16) | 12 (9–16) |
| Composite outcome: AV reoperation or ≥2+ AI (%), n (%) | 14 (20) | 13 (25) | 1 (6) |
| . | Total (n = 71) . | Trileaflet aortic valve (n = 53) . | Bicuspid aortic valve (n = 18) . |
|---|---|---|---|
| Follow-up duration (years), mean (SD) | 3.9 (1.1) | 3.9 (1.2) | 3.9 (1.1) |
| Follow-up duration (years), median (IQR) | 4.1 (1.5) | 4.2 (1.5) | 3.9 (1.8) |
| Completeness of follow-up (%), n (%) | 67 (94) | 50 (94) | 17 (94) |
| Reoperation for aortic valve dysfunction, n (%) | 4 (6) | 3 (6) | 1 (6) |
| NYHA class on most recent follow-up, n (%) | |||
| I | 60 (85) | 45 (85) | 15 (83) |
| II | 10 (14) | 7 (13) | 3 (17) |
| III and IV | 1 (1.4) | 1 (2) | 0 (0) |
| AI grade at most recent follow-up, n (%)a | |||
| Zero trace | 17 (25) | 7 (14) | 10 (56) |
| 1+ | 37 (54) | 30 (60) | 7 (39) |
| 2+ | 10 (15) | 10 (20) | 0 (0) |
| 3+ | 0 (0) | 0 (0) | 0 (0) |
| 4+ | 4 (6)b | 3 (6) | 1 (6) |
| Follow-up mean AV gradient (mmHg), median (IQR) | 10 (8–16) | 10 (8–16) | 12 (9–16) |
| Composite outcome: AV reoperation or ≥2+ AI (%), n (%) | 14 (20) | 13 (25) | 1 (6) |
Three trileaflet patients do not have follow-up AI grades: 2 were lost to follow-up and 1 died prior to follow-up from a cause unrelated to his surgery.
This includes the patients who subsequently underwent reoperation.
AI: aortic insufficiency; AV: aortic valve; IQR: interquartile range; NYHA: New York Heart Association; SD: standard deviation.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
